![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C08B 37/00 | (2006.01) |
C12P 19/04 | (2006.01) |
(11) | Number of the document | 2571902 |
(13) | Kind of document | T |
(96) | European patent application number | 11721756.2 |
Date of filing the European patent application | 2011-05-18 | |
(97) | Date of publication of the European application | 2013-03-27 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-10 |
(46) | Date of publication of the claims translation | 2019-10-10 |
(86) | Number | PCT/EP2011/058016 |
Date | 2011-05-18 |
(87) | Number | WO 2011/144645 |
Date | 2011-11-24 |
(30) | Number | Date | Country code |
201008401 | 2010-05-20 | GB |
(72) |
CHARLES, Philippe, BE
GELDHOF, Geoffroy, BE
MANCUSO, Vincent, BE
|
(73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Naujas būdas |
NOVEL PROCESS |
Payment date | Validity (years) | Amount | |
2025-04-23 | 15 | 289.00 EUR |
2026-05-18 |